Relmada Therapeutics RLMD
NASDAQ RLMD
$3.66 -0.11 (-2.92%)
At close: Oct 1, 2026 · 4:00 PM EDT

Relmada Therapeutics (RLMD) Interest Coverage Ratio (2014 - 2015)

Updated

Relmada Therapeutics' (RLMD) Interest Coverage Ratio was -4882.52 for Q2 2016.

Analysis

Relmada Therapeutics (RLMD) Interest Coverage Ratio (2014 - 2015) Analysis & Trends

Over the twelve months ended Dec 31, 2015, Relmada Therapeutics' Interest Coverage Ratio came in at -186.70; for FY2015, it was -3474.05.

  • By year, Interest Coverage Ratio came in at -1856.95 in FY2014 and -30.75 in FY2013.
  • Five-year quarterly Interest Coverage Ratio spans a low of -36626.46 in Q3 2015 and a high of -60.42 in Q4 2015.
  • Per Business Quant data, the three quarters before Q2 2016 came in at -2819.49 (Q1 2016), -60.42 (Q4 2015) and -36626.46 (Q3 2015).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.41
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 10.28
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 7.27
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 5.22
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -42.08
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Relmada Therapeutics 402.15 Mn 402.15 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 -4,882.52
Sep 30, 2015 -2,819.49
Jun 30, 2015 -60.24
Mar 31, 2015 -36,626.46
Dec 31, 2014 -3,993.52
Sep 30, 2014 -1,139.10
Mar 31, 2014 -5.75
API Access

Relmada Therapeutics Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=RLMD&period=max&api_key=YOUR_API_KEY